PharmaOpinionAlexion Is Hiring Its Own Head of AI Inside an AstraZeneca That Already Has One
Alexion, AstraZeneca's rare disease unit, is hiring a Head of AI in Boston to set enterprise AI strategy across research, regulatory, operations and commercial. AstraZeneca already runs a central Enterprise AI unit under a chief digital, data and AI officer that covers the same functions. The question is whether rare disease needs its own AI leader, or whether the parent risks building two AI agendas.
